Article Details
Retrieved on: 2022-02-14 23:40:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Nasdaq: GILD) released data demonstrating the in vitro activity of Veklury (remdesivir) against ten SARS-CoV-2 variants, including Omicron. Results ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here